speb/financial-data huggingface dataset:
VRNS cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 50569000.00
VRNS cash_flow (annual, 2024-12-31) — Change In Payable: 3641000.00
VRNS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 20958000.00
VRNS cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -35332000.00
VRNS cash_flow (annual, 2024-12-31) — Change In Receivables: -23716000.00
VRNS cash_flow (annual, 2024-12-31) — Change In Working Capital: 13132000.00
VRNS cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -23716000.00
VRNS cash_flow (annual, 2024-12-31) — Changes In Cash: -45155000.00
VRNS balance_sheet (annual, 2024-12-31) — Common Stock: 113000.00
VRNS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 455656000.00
VRNS cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
VRNS income_statement (annual, 2024-12-31) — Cost Of Revenue: 93847000.00
VRNS balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 91279000.00
VRNS balance_sheet (annual, 2024-12-31) — Current Assets: 878074000.00
VRNS balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 10845000.00
VRNS balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 10845000.00
VRNS balance_sheet (annual, 2024-12-31) — Current Debt: 250529000.00
VRNS balance_sheet (quarterly, 2024-12-31) — Current Debt: 250529000.00
VRNS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 261374000.00
VRNS balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 261374000.00
VRNS balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 34132000.00
VRNS balance_sheet (quarterly, 2024-12-31) — Current Deferred Assets: 34132000.00
VRNS balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 290113000.00
VRNS balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 290113000.00
VRNS balance_sheet (annual, 2024-12-31) — Current Liabilities: 709885000.00
VRNS cash_flow (annual, 2024-12-31) — Depreciation: 9863000.00
VRNS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 11126000.00
VRNS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 11126000.00
VRNS income_statement (annual, 2024-12-31) — Diluted Average Shares: 111660541.00
VRNS income_statement (annual, 2024-12-31) — Diluted EPS: -0.86
VRNS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -95765000.00
VRNS income_statement (annual, 2024-12-31) — EBIT: -78436000.00
VRNS income_statement (annual, 2024-12-31) — EBITDA: -67310000.00
VRNS cash_flow (annual, 2024-12-31) — End Cash Position: 185585000.00
VRNS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 371900000.00
VRNS cash_flow (annual, 2024-12-31) — Free Cash Flow: 101853000.00
VRNS cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
VRNS income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -827000.00
VRNS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 2676000.00
VRNS income_statement (annual, 2024-12-31) — General And Administrative Expense: 89220000.00
VRNS balance_sheet (annual, 2024-12-31) — Goodwill: 23135000.00
VRNS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 23135000.00
VRNS balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 195350000.00
VRNS balance_sheet (annual, 2024-12-31) — Gross PPE: 127666000.00
VRNS income_statement (annual, 2024-12-31) — Gross Profit: 457103000.00
VRNS balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 8099000.00
VRNS balance_sheet (quarterly, 2024-12-31) — Hedging Assets Current: 8099000.00
VRNS cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 24249000.00
VRNS income_statement (annual, 2024-12-31) — Interest Expense: 4571000.00
VRNS income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 4571000.00
VRNS income_statement (annual, 2024-12-31) — Interest Income: 30355000.00
VRNS income_statement (annual, 2024-12-31) — Interest Income Non Operating: 30355000.00
VRNS cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 3193000.00
VRNS balance_sheet (annual, 2024-12-31) — Invested Capital: 1156428000.00
VRNS cash_flow (annual, 2024-12-31) — Investing Cash Flow: -532255000.00
VRNS balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 658896000.00
VRNS balance_sheet (annual, 2024-12-31) — Investments And Advances: 658896000.00
VRNS cash_flow (annual, 2024-12-31) — Issuance Of Debt: 449635000.00
VRNS cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: -464000.00
VRNS balance_sheet (annual, 2024-12-31) — Leases: 45062000.00
VRNS balance_sheet (quarterly, 2024-12-31) — Leases: 45062000.00
VRNS balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 42789000.00
VRNS balance_sheet (annual, 2024-12-31) — Long Term Debt: 450243000.00
VRNS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 493032000.00
VRNS cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 449635000.00
VRNS cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: -464000.00
VRNS cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
VRNS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 37011000.00
VRNS balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 37011000.00
VRNS cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
VRNS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
VRNS balance_sheet (annual, 2024-12-31) — Net Debt: 515187000.00
VRNS income_statement (annual, 2024-12-31) — Net Income: -95765000.00
VRNS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -95765000.00
VRNS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -95765000.00
VRNS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -95765000.00
VRNS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -95765000.00
VRNS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -95765000.00
VRNS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -95765000.00
VRNS cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -6653000.00
VRNS cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
VRNS income_statement (annual, 2024-12-31) — Net Interest Income: 22781000.00
VRNS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -518908000.00
VRNS cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 449635000.00
VRNS cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -464000.00
VRNS cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 449635000.00
VRNS cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -464000.00
VRNS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 22781000.00
VRNS cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -93817000.00
VRNS balance_sheet (annual, 2024-12-31) — Net PPE: 76388000.00
VRNS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -6694000.00
VRNS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 432521000.00
VRNS balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 2211000.00
VRNS balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 2211000.00
VRNS income_statement (annual, 2024-12-31) — Normalized EBITDA: -66483000.00
VRNS income_statement (annual, 2024-12-31) — Normalized Income: -95111670.00
VRNS cash_flow (annual, 2024-12-31) — Operating Cash Flow: 115200000.00
VRNS income_statement (annual, 2024-12-31) — Operating Income: -117651000.00
VRNS income_statement (annual, 2024-12-31) — Operating Revenue: 550950000.00
VRNS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 112550156.00
VRNS balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 250529000.00
VRNS balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 250529000.00
VRNS balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 62806000.00
VRNS balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 62806000.00
VRNS balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 2676000.00
VRNS income_statement (annual, 2024-12-31) — Other Gand A: 89220000.00
VRNS income_statement (annual, 2024-12-31) — Other Income Expense: 11863000.00
VRNS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 72715000.00
VRNS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 27782000.00
VRNS balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 3491000.00
VRNS balance_sheet (annual, 2024-12-31) — Other Properties: 45593000.00
VRNS balance_sheet (annual, 2024-12-31) — Other Receivables: 46053000.00
VRNS balance_sheet (quarterly, 2024-12-31) — Other Receivables: 46053000.00
VRNS balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 382833000.00
VRNS balance_sheet (annual, 2024-12-31) — Payables: 4313000.00
VRNS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 95592000.00
VRNS balance_sheet (annual, 2024-12-31) — Prepaid Assets: 28540000.00
VRNS balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 28540000.00
VRNS income_statement (annual, 2024-12-31) — Pretax Income: -83007000.00
VRNS cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 16082000.00
VRNS balance_sheet (annual, 2024-12-31) — Properties: 0.00
VRNS balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
VRNS cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
VRNS cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -6653000.00
VRNS cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: 0.00
VRNS cash_flow (annual, 2024-12-31) — Purchase Of Investment: -974095000.00
VRNS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -6694000.00
VRNS balance_sheet (annual, 2024-12-31) — Receivables: 238885000.00
VRNS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 93847000.00
VRNS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 11126000.00
VRNS cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
VRNS cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
VRNS income_statement (annual, 2024-12-31) — Research And Development: 196765000.00
VRNS balance_sheet (annual, 2024-12-31) — Retained Earnings: -740155000.00
VRNS cash_flow (annual, 2024-12-31) — Sale Of Investment: 455187000.00
VRNS cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
VRNS income_statement (annual, 2024-12-31) — Securities Amortization: -12690000.00
VRNS income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 288769000.00
VRNS income_statement (annual, 2024-12-31) — Selling General And Administration: 377989000.00
VRNS balance_sheet (annual, 2024-12-31) — Share Issued: 112550156.00
VRNS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 126682000.00
VRNS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 455656000.00
VRNS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 432521000.00
VRNS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -173670.00
VRNS income_statement (annual, 2024-12-31) — Tax Provision: 12758000.00
VRNS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
VRNS balance_sheet (annual, 2024-12-31) — Total Assets: 1664275000.00
VRNS balance_sheet (annual, 2024-12-31) — Total Capitalization: 905899000.00
VRNS balance_sheet (annual, 2024-12-31) — Total Debt: 754406000.00
VRNS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 455656000.00
VRNS income_statement (annual, 2024-12-31) — Total Expenses: 668601000.00
VRNS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1208619000.00
VRNS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 786201000.00
VRNS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 498734000.00
VRNS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -117651000.00
VRNS income_statement (annual, 2024-12-31) — Total Other Finance Cost: 3003000.00
VRNS income_statement (annual, 2024-12-31) — Total Unusual Items: -827000.00
VRNS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -827000.00
VRNS balance_sheet (annual, 2024-12-31) — Working Capital: 168189000.00
VRNS income_statement (quarterly, 2025-03-31) — +Operating Expense: 151171000.00
VRNS income_statement (quarterly, 2025-03-31) — +Total Revenue: 136423000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 6274000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 123579000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1144730000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -2336000.00
VRNS income_statement (quarterly, 2025-03-31) — Amortization: 603000.00
VRNS income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 603000.00
VRNS cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: 99000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 591702000.00
VRNS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 112651178.00
VRNS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.32
VRNS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 185585000.00
VRNS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -2664000.00
VRNS cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -325000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 40559000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 113000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 153107000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 609219000.00
VRNS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -75461000.00
VRNS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -25017000.00
VRNS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 68000000.00
VRNS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 1961000.00
VRNS cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -16728000.00
VRNS cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 12000.00
VRNS cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 458000.00
VRNS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -7615000.00
VRNS cash_flow (quarterly, 2025-03-31) — Change In Payable: 1961000.00
VRNS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -14767000.00
VRNS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 11077000.00
VRNS cash_flow (quarterly, 2025-03-31) — Change In Receivables: 65129000.00
VRNS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 54294000.00
VRNS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 65129000.00
VRNS cash_flow (quarterly, 2025-03-31) — Changes In Cash: -32478000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Common Stock: 113000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 367743000.00
VRNS cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -61264000.00
VRNS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 29018000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 156780000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Current Assets: 818090000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Current Debt: 250912000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 250912000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 296142000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 296142000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 710108000.00
VRNS cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 0.00
VRNS cash_flow (quarterly, 2025-03-31) — Deferred Tax: 0.00
VRNS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2419000.00
VRNS income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 603000.00
VRNS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2419000.00
VRNS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 603000.00
VRNS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 112651178.00
VRNS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.32
VRNS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -35783000.00
VRNS income_statement (quarterly, 2025-03-31) — EBIT: -43766000.00
VRNS income_statement (quarterly, 2025-03-31) — EBITDA: -41347000.00
VRNS cash_flow (quarterly, 2025-03-31) — End Cash Position: 153107000.00
VRNS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -75461000.00
VRNS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 65336000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -1162000.00
VRNS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 23595000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Goodwill: 39750000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 45764000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 125915000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 74613000.00
VRNS income_statement (quarterly, 2025-03-31) — Gross Profit: 107405000.00
VRNS cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 894000.00
VRNS income_statement (quarterly, 2025-03-31) — Interest Income: 11951000.00
VRNS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 11951000.00
VRNS cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 3938000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1069401000.00
VRNS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -25017000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 591702000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 591702000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 40559000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 450746000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 491305000.00
VRNS cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -18584000.00
VRNS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -61264000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Net Debt: 548551000.00
VRNS income_statement (quarterly, 2025-03-31) — Net Income: -35783000.00
VRNS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -35783000.00
VRNS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -35783000.00
VRNS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -35783000.00
VRNS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -35783000.00
VRNS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -35783000.00
VRNS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -35783000.00
VRNS income_statement (quarterly, 2025-03-31) — Net Interest Income: 11951000.00
VRNS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -3769000.00
VRNS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 11951000.00
VRNS cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -21360000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Net PPE: 74613000.00
VRNS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -2339000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 321979000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 126000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 126000.00
VRNS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -41347000.00
VRNS income_statement (quarterly, 2025-03-31) — Normalized Income: -35783000.00
VRNS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 68000000.00
VRNS income_statement (quarterly, 2025-03-31) — Operating Income: -43766000.00
VRNS income_statement (quarterly, 2025-03-31) — Operating Revenue: 136423000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 112882608.00
VRNS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 85292000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 250912000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -1162000.00
VRNS income_statement (quarterly, 2025-03-31) — Other Gand A: 23595000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 6014000.00
VRNS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 14716000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 46925000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 7812000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Other Properties: 74613000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 456112000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Payables: 6274000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 163054000.00
VRNS income_statement (quarterly, 2025-03-31) — Pretax Income: -31815000.00
VRNS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 7163000.00
VRNS cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -18584000.00
VRNS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -93943000.00
VRNS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -2339000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Receivables: 123579000.00
VRNS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 27202000.00
VRNS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2419000.00
VRNS cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -61264000.00
VRNS income_statement (quarterly, 2025-03-31) — Research And Development: 54210000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -775938000.00
VRNS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 90174000.00
VRNS income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 72763000.00
VRNS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 96358000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Share Issued: 112882608.00
VRNS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 32255000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 367743000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 321979000.00
VRNS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
VRNS income_statement (quarterly, 2025-03-31) — Tax Provision: 3968000.00
VRNS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
VRNS balance_sheet (quarterly, 2025-03-31) — Total Assets: 1577094000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 818489000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Total Debt: 742217000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 367743000.00
VRNS income_statement (quarterly, 2025-03-31) — Total Expenses: 180189000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1209351000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 759004000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 499243000.00
VRNS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -43766000.00
VRNS balance_sheet (quarterly, 2025-03-31) — Working Capital: 107982000.00
VRNS income_statement (quarterly, 2025-06-30) — +Operating Expense: 157466000.00
VRNS income_statement (quarterly, 2025-06-30) — +Total Revenue: 152163000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 7115000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 149703000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1138652000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -2014000.00
VRNS cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: 315000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 364203000.00
VRNS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 112054715.00
VRNS income_statement (quarterly, 2025-06-30) — Basic EPS: -0.32
VRNS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 153107000.00
VRNS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -4027000.00
VRNS cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -650000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 39865000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 112000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 199231000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 807448000.00
VRNS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -45175000.00
VRNS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 69950000.00
VRNS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 21349000.00
VRNS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 841000.00
VRNS cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 32681000.00
VRNS cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -1132000.00
VRNS cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 571000.00
VRNS cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 6093000.00
VRNS cash_flow (quarterly, 2025-06-30) — Change In Payable: 841000.00
VRNS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 33522000.00
VRNS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -9650000.00
VRNS cash_flow (quarterly, 2025-06-30) — Change In Receivables: -26125000.00
VRNS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 3279000.00
VRNS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -26125000.00
VRNS cash_flow (quarterly, 2025-06-30) — Changes In Cash: 46124000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Common Stock: 112000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 341499000.00
VRNS cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -38736000.00
VRNS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 31249000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 190344000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Current Assets: 1068363000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Current Debt: 251148000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 251148000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 322791000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 322791000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 771398000.00
VRNS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2569000.00
VRNS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2569000.00
VRNS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 112054715.00
VRNS income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.32
VRNS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -35824000.00
VRNS income_statement (quarterly, 2025-06-30) — EBIT: -36552000.00
VRNS income_statement (quarterly, 2025-06-30) — EBITDA: -33983000.00
VRNS cash_flow (quarterly, 2025-06-30) — End Cash Position: 199231000.00
VRNS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -45175000.00
VRNS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 17322000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 14497000.00
VRNS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 24641000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Goodwill: 39750000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 45594000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 151717000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 74831000.00
VRNS income_statement (quarterly, 2025-06-30) — Gross Profit: 120914000.00
VRNS cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 4372000.00
VRNS income_statement (quarterly, 2025-06-30) — Interest Income: 4967000.00
VRNS income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 4967000.00
VRNS cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 7000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1043894000.00
VRNS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 69950000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 364203000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 364203000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 39865000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 451247000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 491112000.00
VRNS cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
VRNS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -38736000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Net Debt: 503164000.00
VRNS income_statement (quarterly, 2025-06-30) — Net Income: -35824000.00
VRNS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -35824000.00
VRNS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -35824000.00
VRNS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -35824000.00
VRNS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -35824000.00
VRNS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -35824000.00
VRNS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -35824000.00
VRNS income_statement (quarterly, 2025-06-30) — Net Interest Income: 4967000.00
VRNS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 75477000.00
VRNS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 4967000.00
VRNS cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -6439000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Net PPE: 74831000.00
VRNS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -3377000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 295905000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 108000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 108000.00
VRNS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -33983000.00
VRNS income_statement (quarterly, 2025-06-30) — Normalized Income: -35824000.00
VRNS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 21349000.00
VRNS income_statement (quarterly, 2025-06-30) — Operating Income: -36552000.00
VRNS income_statement (quarterly, 2025-06-30) — Operating Revenue: 152163000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 112047109.00
VRNS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 111212000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 251148000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 14497000.00
VRNS income_statement (quarterly, 2025-06-30) — Other Gand A: 24641000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 5844000.00
VRNS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 17151000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 62021000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 10895000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Other Properties: 74831000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 608217000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Payables: 7115000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 197459000.00
VRNS income_statement (quarterly, 2025-06-30) — Pretax Income: -31585000.00
VRNS cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
VRNS cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
VRNS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -60099000.00
VRNS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -3377000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Receivables: 149703000.00
VRNS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 31249000.00
VRNS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2569000.00
VRNS cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -38736000.00
VRNS income_statement (quarterly, 2025-06-30) — Research And Development: 56247000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -811762000.00
VRNS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 135576000.00
VRNS income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 76578000.00
VRNS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 101219000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Share Issued: 112047109.00
VRNS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 33859000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 341499000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 295905000.00
VRNS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
VRNS income_statement (quarterly, 2025-06-30) — Tax Provision: 4239000.00
VRNS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
VRNS balance_sheet (quarterly, 2025-06-30) — Total Assets: 1615012000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 792746000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Total Debt: 742260000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 341499000.00
VRNS income_statement (quarterly, 2025-06-30) — Total Expenses: 188715000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1273513000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 546649000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 502115000.00
VRNS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -36552000.00
VRNS balance_sheet (quarterly, 2025-06-30) — Working Capital: 296965000.00
VRNS income_statement (quarterly, 2025-09-30) — +Operating Expense: 162362000.00
VRNS income_statement (quarterly, 2025-09-30) — +Total Revenue: 161577000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 5261000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 142628000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1428039000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -2332000.00
VRNS cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: 797000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 395651000.00
VRNS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 114974455.00
VRNS income_statement (quarterly, 2025-09-30) — Basic EPS: -0.26
VRNS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 199231000.00
VRNS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -4505000.00
VRNS cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -1534000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 59921000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 118000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 157354000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 707921000.00
VRNS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 6418000.00
VRNS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -81693000.00
VRNS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 33398000.00
VRNS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -2047000.00
VRNS cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 7467000.00
VRNS cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 841000.00
VRNS cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 546000.00
VRNS cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -6105000.00
VRNS cash_flow (quarterly, 2025-09-30) — Change In Payable: -2047000.00
VRNS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 5420000.00
VRNS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 2781000.00
VRNS cash_flow (quarterly, 2025-09-30) — Change In Receivables: 7530000.00
VRNS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 11013000.00
VRNS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 7530000.00
VRNS cash_flow (quarterly, 2025-09-30) — Changes In Cash: -41877000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Common Stock: 118000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 604835000.00
VRNS cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
VRNS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 35149000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 193074000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Current Assets: 961386000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 333578000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 333578000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 531913000.00
VRNS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2976000.00
VRNS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2976000.00
VRNS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 114974455.00
VRNS income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.26
VRNS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -29942000.00
VRNS income_statement (quarterly, 2025-09-30) — EBIT: -35934000.00
VRNS income_statement (quarterly, 2025-09-30) — EBITDA: -32958000.00
VRNS cash_flow (quarterly, 2025-09-30) — End Cash Position: 157354000.00
VRNS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 6418000.00
VRNS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 28893000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 18382000.00
VRNS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 25600000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Goodwill: 135176000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 152508000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 144960000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 93899000.00
VRNS income_statement (quarterly, 2025-09-30) — Gross Profit: 126428000.00
VRNS cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 1559000.00
VRNS income_statement (quarterly, 2025-09-30) — Interest Income: 7806000.00
VRNS income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 7806000.00
VRNS cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 3774000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1056589000.00
VRNS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -81693000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 395651000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 395651000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 59921000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 451754000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 511675000.00
VRNS cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -104930000.00
VRNS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
VRNS balance_sheet (quarterly, 2025-09-30) — Net Debt: 294400000.00
VRNS income_statement (quarterly, 2025-09-30) — Net Income: -29942000.00
VRNS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -29942000.00
VRNS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -29942000.00
VRNS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -29942000.00
VRNS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -29942000.00
VRNS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -29942000.00
VRNS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -29942000.00
VRNS income_statement (quarterly, 2025-09-30) — Net Interest Income: 7806000.00
VRNS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 26242000.00
VRNS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 7806000.00
VRNS cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -631000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Net PPE: 93899000.00
VRNS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -2971000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 452327000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 7930000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 7930000.00
VRNS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -32958000.00
VRNS income_statement (quarterly, 2025-09-30) — Normalized Income: -29942000.00
VRNS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 33398000.00
VRNS income_statement (quarterly, 2025-09-30) — Operating Income: -35934000.00
VRNS income_statement (quarterly, 2025-09-30) — Operating Revenue: 161577000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 117897308.00
VRNS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 110837000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 18382000.00
VRNS income_statement (quarterly, 2025-09-30) — Other Gand A: 25600000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 17332000.00
VRNS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 17004000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 61562000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 8653000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Other Properties: 93899000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 550567000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Payables: 5261000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 198335000.00
VRNS income_statement (quarterly, 2025-09-30) — Pretax Income: -28128000.00
VRNS cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 7186000.00
VRNS cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -104930000.00
VRNS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -231493000.00
VRNS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -2971000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Receivables: 142628000.00
VRNS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 35149000.00
VRNS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2976000.00
VRNS cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
VRNS income_statement (quarterly, 2025-09-30) — Research And Development: 62737000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -841704000.00
VRNS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 257735000.00
VRNS income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 74025000.00
VRNS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 99625000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Share Issued: 117897308.00
VRNS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 31550000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 604835000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 452327000.00
VRNS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
VRNS income_statement (quarterly, 2025-09-30) — Tax Provision: 1814000.00
VRNS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
VRNS balance_sheet (quarterly, 2025-09-30) — Total Assets: 1665006000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1056589000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Total Debt: 511675000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 604835000.00
VRNS income_statement (quarterly, 2025-09-30) — Total Expenses: 197511000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1060171000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 703620000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 528258000.00
VRNS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -35934000.00
VRNS balance_sheet (quarterly, 2025-09-30) — Working Capital: 429473000.00
VRNS income_statement (annual, 2025-12-31) — +Operating Expense: 638072000.00
VRNS income_statement (quarterly, 2025-12-31) — +Operating Expense: 167073000.00
VRNS income_statement (annual, 2025-12-31) — +Total Revenue: 623532000.00
VRNS income_statement (quarterly, 2025-12-31) — +Total Revenue: 173369000.00
VRNS balance_sheet (annual, 2025-12-31) — Accounts Payable: 5735000.00
VRNS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 5735000.00
VRNS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 242822000.00
VRNS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 242822000.00
VRNS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -56240000.00
VRNS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -56240000.00
VRNS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1444885000.00
VRNS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1444885000.00
VRNS balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1260000.00
VRNS balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1260000.00
VRNS cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 1053000.00
VRNS cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 1053000.00
VRNS cash_flow (annual, 2025-12-31) — Amortization Of Securities: 2267000.00
VRNS cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: 1056000.00
VRNS balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 187202000.00
VRNS balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 187202000.00
VRNS income_statement (annual, 2025-12-31) — Basic Average Shares: 114413076.00